Pulmonary manifestations of connective-tissue disease (CTD) may arise before, during, or years after the onset of articular disease. Interstitial lung disease (ILD) is the most common pulmonary manifestation of rheumatoid arthritis (RA) and may develop as a result of chronic immune activation and inflammation with subsequent aberrant fibroproliferation. It may also be rooted in drug-related or infectious causes. Although there is a paucity of robust evidence to support current recommendations, management of RA-ILD comprises both supportive measures and treatment against the inflammatory processes responsible for its pathogenesis. Although the American College of Rheumatology recommendations do not specifically address the co-occurrence of RA and ILD, consensus does suggest that extra-articular disease carries a less favorable prognosis and therefore should receive more aggressive treatment.
How much do you know about managing ILD in the context of RA? Test your knowledge with this quick quiz.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Zab Mosenifar. Fast Five Quiz: Rheumatoid Arthritis Interstitial Lung Disease Management - Medscape - Apr 05, 2021.